Hydralazine Hydrochloride

CAS 304-20-1 15 current records 8 historicalSmall Molecule

Who holds supplier records for Hydralazine Hydrochloride? 15 organisations hold a current record for Hydralazine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (12), Japan (1), Italy (1) and United States (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Hydralazine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/hydralazine-hydrochloride

Reading the evidence

  • 15 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    12 of the 15 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 11 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (15)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Hydralazine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Hydralazine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Hydralazine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HETERO LABS LIMITED HyderabadIN
CEP 2018-287 - Rev 04
Hydralazine hydrochloride
Sept 2026—
AMI LIFESCIENCES PRIVATE LIMITED VadodaraIN
CEP 2025-174 - Rev 00
Hydralazine hydrochloride
Jun 2026Inspected Oct 2025
Slovakia
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2013-191 - Rev 04
Hydralazine hydrochloride
May 2026—
D. K. PHARMA CHEM PRIVATE LIMITED BadlapurIN
CEP 2023-431 - Rev 00
Hydralazine hydrochloride
Aug 2025Inspected Mar 2024
Sweden
SUMITOMO CHEMICAL COMPANY LIMITED OsakaJP
CEP 2018-170 - Rev 03
Hydralazine hydrochloride
Oct 2024—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
R1-CEP 2016-180 - Rev 00
Hydralazine hydrochloride
Mar 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Hydralazine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • DK PHARMA CHEM PVT LTD
    Inactive DMF 21953 · filed Sept 2008
  • SHANDONG WEIFANG PHARMACEUTICAL FACTORY CO LTD
    Inactive DMF 19209 · filed Feb 2006
  • SIEGFRIED AG
    Inactive DMF 5720 · filed Feb 1985
  • DAIWA PHARMACEUTICAL CO LTD
    Inactive DMF 5611 · filed Dec 1984
  • PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKS
    Inactive DMF 4274 · filed Sept 1981
  • POLIPHARM SPA
    Inactive DMF 3918 · filed Jul 1980
  • COWAY CHEMICAL CO LTD
    Inactive DMF 3450 · filed Jan 1979
  • ALLIED CHEMICAL CORP
    Inactive DMF 1909 · filed Mar 1972

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Hydralazine Hydrochloride is a potent vasodilator used in the treatment of hypertension and heart failure. It works by relaxing blood vessels, improving blood flow, and decreasing cardiac workload.

Chemical identity

IUPAC name
phthalazin-1-ylhydrazine;hydrochloride
Canonical SMILES
C1=CC=C2C(=C1)C=NN=C2NN.Cl
InChIKey
ZUXNZUWOTSUBMN-UHFFFAOYSA-N
Synonyms
Apresoline API, apresoline, apressinum, dralzine, hydralazine hcl, hydralazini hydrochloridum, mc-1101, nsc-89394

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Arteriolar Vasodilator
Physiologic effect
Arteriolar Vasodilation

Therapeutic areas

Cardiovascular DiseasesHypertension

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Hydralazine Hydrochloride?

15 organisations hold an active US FDA Type II Drug Master File or a CEP for Hydralazine Hydrochloride: AMI LIFESCIENCES PRIVATE LTD (India), Hetero Labs Limited (India), Macleods Pharmaceuticals Ltd. (India), SOLARA ACTIVE PHARMA SCIENCES LTD (India), SUMITOMO CHEMICAL CO LTD (Japan), ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India) and ARCHIMICA SPA (Italy), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Hydralazine Hydrochloride Drug Master Files are active?

AMI LIFESCIENCES PRIVATE LTD (DMF 41646), Hetero Labs Limited (DMF 25411, 20520), Macleods Pharmaceuticals Ltd. (DMF 30354), SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 22633), SUMITOMO CHEMICAL CO LTD (DMF 2421), ALIVUS LIFE SCIENCES LTD (DMF 35807), APITORIA PHARMA PRIVATE LTD (DMF 32019) and ARCHIMICA SPA (DMF 22169) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Hydralazine Hydrochloride records mean?

8 organisations have only inactive Type II DMFs for Hydralazine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Hydralazine Hydrochloride have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Hydralazine Hydrochloride on the EDQM register, including HETERO LABS LIMITED Hyderabad (IN), AMI LIFESCIENCES PRIVATE LIMITED Vadodara (IN), SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai (IN), D. K. PHARMA CHEM PRIVATE LIMITED Badlapur (IN), SUMITOMO CHEMICAL COMPANY LIMITED Osaka (JP) and MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Hydralazine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Hydralazine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.